Brain training eyed as way to sharpen blurry vision in keratoconus

NCT ID NCT05220904

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers are testing whether perceptual learning, a computer-based training that aims to improve how the brain processes visual information, can help people with stable keratoconus see better with their glasses. The study enrolls people aged 9 and older whose best corrected vision is still unsatisfactory. Participants are randomly assigned to receive either perceptual learning training or standard spectacle correction, and researchers measure changes in corrected and uncorrected vision and contrast sensitivity over 15 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
perceptual learning, a computer-based visual training program
What this could lead to
If it works, perceptual learning could offer a non-surgical way to help people with keratoconus see more clearly with their glasses.
What could go wrong
This is a small study of 35 people with stable keratoconus, so results may not apply to everyone. Any vision gains might fade over time, and training takes repeated sessions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

35 people

The number who actually took part.

Started

Feb 2022

Finished

Sep 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

9 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged 9 years or older; 2. Has been diagnosed as Keratoconus,BAD-D≥2.6; 3. Change of Kmax \< 1.0 D and change of BAD-D \<0.4175 betweem the last two Pentacam result; 4. The best corrected visual acuity of both eyes was between 0.1 and 1.0; 5. Has voluntarily agreed to participate in the study by signing the statement of informed consent. Exclusion Criteria: 1. Has history of acute keratoconus; 2. Has other eye diseases or other diseases/conditions causing vision loss; 3. Has eye surgery history in the past 1year; 4. Is currently using local/systemic medications or other interventions that may affect visual function; 5. Receiving other treatments that may affect the results of this study, such as contact lenses during the study; 6. Has any known neurological diseases; 7. Participating in other studies currently that may affect the results of this study; 8. Study other reasons that the physician considers inappropriate for inclusion in the program.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Keratoconus, stable are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    Guangzhou, Guangdong, 510060, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.